These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30403540)

  • 1. Liraglutide Promotes the Osteogenic Differentiation in MC3T3-E1 Cells via Regulating the Expression of Smad2/3 Through PI3K/Akt and Wnt/β-Catenin Pathways.
    Gao L; Li SL; Li YK
    DNA Cell Biol; 2018 Dec; 37(12):1031-1043. PubMed ID: 30403540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
    Wu X; Li S; Xue P; Li Y
    Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide Inhibits the Apoptosis of MC3T3-E1 Cells Induced by Serum Deprivation through cAMP/PKA/β-Catenin and PI3K/AKT/GSK3β Signaling Pathways.
    Wu X; Li S; Xue P; Li Y
    Mol Cells; 2018 Mar; 41(3):234-243. PubMed ID: 29463067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway.
    Li Y; Fu H; Wang H; Luo S; Wang L; Chen J; Lu H
    Mol Cell Endocrinol; 2020 Sep; 515():110921. PubMed ID: 32615283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
    Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
    Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide regulates proliferation, differentiation, and apoptosis of preosteoblasts through a signaling network of Notch/Wnt/Hedgehog signaling pathways.
    Hou HW; Xue P; Wang Y; Li YK
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12408-12422. PubMed ID: 33336762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the effects of naringin on oxidative stress-impaired osteogenic differentiation via the Wnt/β-catenin and PI3K/Akt pathways.
    Wang H; Liang J; Wang Y; Zheng J; Liu Y; Zhao Y; Ma Y; Chen P; Yang X
    Sci Rep; 2024 Jun; 14(1):14047. PubMed ID: 38890371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural Cell Adhesion Molecule Regulates Osteoblastic Differentiation Through Wnt/β-Catenin and PI3K-Akt Signaling Pathways in MC3T3-E1 Cells.
    Cheng BF; Feng X; Gao YX; Jian SQ; Liu SR; Wang M; Xie YF; Wang L; Feng ZW; Yang HJ
    Front Endocrinol (Lausanne); 2021; 12():657953. PubMed ID: 34054729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Pretreatment with Quercetin Against Lipopolysaccharide-Induced Apoptosis and the Inhibition of Osteoblast Differentiation via the MAPK and Wnt/β-Catenin Pathways in MC3T3-E1 Cells.
    Guo C; Yang RJ; Jang K; Zhou XL; Liu YZ
    Cell Physiol Biochem; 2017; 43(4):1547-1561. PubMed ID: 29035884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects and mechanism of paeoniflorin in promoting osteogenic differentiation of MC3T3-E1.
    Guo W; Yang XG; Shi YL; Wang H
    J Orthop Surg Res; 2022 Feb; 17(1):90. PubMed ID: 35164817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1RA promotes brown adipogenesis of C3H10T1/2 mesenchymal stem cells via the PI3K-AKT-mTOR signaling pathway.
    Wang X; Chen J; Rong C; Pan F; Zhao X; Hu Y
    Biochem Biophys Res Commun; 2018 Dec; 506(4):976-982. PubMed ID: 30404729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of GLP-1 Receptor Promotes Bone Marrow Stromal Cell Osteogenic Differentiation through β-Catenin.
    Meng J; Ma X; Wang N; Jia M; Bi L; Wang Y; Li M; Zhang H; Xue X; Hou Z; Zhou Y; Yu Z; He G; Luo X
    Stem Cell Reports; 2016 Apr; 6(4):579-591. PubMed ID: 26947974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.
    Chen LL; Huang M; Tan JY; Chen XT; Lei LH; Wu YM; Zhang DY
    Tissue Eng Part A; 2013 Oct; 19(19-20):2226-32. PubMed ID: 23617625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4 promotes proliferation and differentiation of MC3T3-E1 osteoblasts by MAPKs activation.
    Feng Y; Su L; Zhong X; Guohong W; Xiao H; Li Y; Xiu L
    J Mol Endocrinol; 2016 Apr; 56(3):189-99. PubMed ID: 26647389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Lipoic Acid Alleviates High-Glucose Suppressed Osteogenic Differentiation of MC3T3-E1 Cells via Antioxidant Effect and PI3K/Akt Signaling Pathway.
    Dong K; Hao P; Xu S; Liu S; Zhou W; Yue X; Rausch-Fan X; Liu Z
    Cell Physiol Biochem; 2017; 42(5):1897-1906. PubMed ID: 28772267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of GLP-1 analogue in arterial calcification through attenuating osteoblastic differentiation of human VSMCs.
    Zhan JK; Wang YJ; Wang Y; Tang ZY; Tan P; Huang W; Liu YS
    Int J Cardiol; 2015 Jun; 189():188-93. PubMed ID: 25897902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway.
    Chen Y; Hu Y; Yang L; Zhou J; Tang Y; Zheng L; Qin P
    Cell Biol Int; 2017 Aug; 41(8):822-832. PubMed ID: 28462510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 analogue liraglutide facilitates wound healing by activating PI3K/Akt pathway in keratinocytes.
    Nagae K; Uchi H; Morino-Koga S; Tanaka Y; Oda M; Furue M
    Diabetes Res Clin Pract; 2018 Dec; 146():155-161. PubMed ID: 30367901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
    Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
    Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSI1 Stabilizes MACF1 to Inhibit Apoptosis of MC3T3-E1 Cells Induced by High Glucose and Promote Osteogenic Differentiation Through Wnt/β-Catenin Signaling Pathway.
    Zou L; Xiang C; Lu M
    Mol Biotechnol; 2023 Jul; 65(7):1085-1095. PubMed ID: 36443618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.